The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative ...

Arcellx (NASDAQ:ACLX) announced an update for its Phase 3 iMMagine-3 study and plans to present Phase 1 and 2 data for its therapy candidate anito-cel for the treatment of multiple myeloma. The ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

"Angitia doses first subject in Phase II trial of AGA2118 for treating osteoporosis" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The self-service returns trial 'removes the need for customers to queue at the customer service desk' the supermarket said ...